Latest filing published 17 Sept 2020 for Chinook Therapeutics, INC., €66k.
Filing timeline
BuySaleInsider track record
Stephen T. Isaacs: trading record in brief
Stephen T. Isaacs is a declared insider of Chinook Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 94 filings, for trades running from 20 April 2015 to 15 September 2020.
Sales make up the whole of the open-market record (43 sales, €8.7M). Besides market trades, the filings include 6 share grants and 39 option exercises. So far in 2020, the count stands at no purchases and 1 sale.
The newest entry dates from 17 September 2020: an open-market sale of €66k, in Chinook Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen T. Isaacs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 32,481 shares@ US$2.399.6% of flowCommon StockSEC:0001567619-20-016854:0
- 21,618 shares@ US$0.451.3% of flowCommon StockSEC:0001567619-20-006851:0
- 5,897 shares@ US$1.160.5% of flowCommon StockSEC:0001567619-19-023141:0
- 31,098 shares@ US$1.311.9% of flowCommon StockSEC:0001567619-19-018457:0
- 5,829 shares@ US$2.930.5% of flowCommon StockSEC:0001567619-18-008013:0
- 151,250 shares0Common StockSEC:0001567619-18-002680:0
- 24,143 shares@ US$6.503.5% of flowCommon StockSEC:0001567619-18-002680:1
- 15,585 shares@ US$1.000.3% of flowCommon StockSEC:0001567619-18-002236:0
- 15,585 shares@ US$7.902.7% of flowCommon StockSEC:0001567619-18-002236:1
- 46,987 shares@ US$1.001.0% of flowCommon StockSEC:0001567619-18-002236:2
- 46,987 shares@ US$7.928.2% of flowCommon StockSEC:0001567619-18-002236:3
- 40,000 shares@ US$1.000.4% of flowCommon StockSEC:0001140361-18-027485:0
- 40,000 shares@ US$8.683.8% of flowCommon StockSEC:0001140361-18-027485:1
- 5,688 shares@ US$0.820.1% of flowCommon StockSEC:0001140361-18-023077:0
- 34,312 shares@ US$1.000.4% of flowCommon StockSEC:0001140361-18-023077:1
- 40,000 shares@ US$8.00873.5% of flowCommon StockSEC:0001140361-18-023077:2
- 40,000 shares@ US$0.820.3% of flowCommon StockSEC:0001209191-18-023891:0
- 40,000 shares@ US$8.913.7% of flowCommon StockSEC:0001209191-18-023891:1
- 25,634 shares@ US$0.450.1% of flowCommon StockSEC:0001209191-18-018641:0
- 25,634 shares@ US$7.952.1% of flowCommon StockSEC:0001209191-18-018641:1
- 15,676 shares@ US$0.450.1% of flowCommon StockSEC:0001209191-18-018641:2
- 19,672 shares@ US$0.450.1% of flowCommon StockSEC:0001209191-18-018641:3
- 4,914 shares@ US$0.450.0% of flowCommon StockSEC:0001209191-18-018641:4
- 6,155 shares@ US$0.820.1% of flowCommon StockSEC:0001209191-18-018641:5
- 25,812 shares@ US$8.5892.3% of flowCommon StockSEC:0001209191-18-018641:6
25 of 94 declarations
